CN103202943A - Powder for treating herpes simplex by using abelmosk - Google Patents

Powder for treating herpes simplex by using abelmosk Download PDF

Info

Publication number
CN103202943A
CN103202943A CN2013100675657A CN201310067565A CN103202943A CN 103202943 A CN103202943 A CN 103202943A CN 2013100675657 A CN2013100675657 A CN 2013100675657A CN 201310067565 A CN201310067565 A CN 201310067565A CN 103202943 A CN103202943 A CN 103202943A
Authority
CN
China
Prior art keywords
parts
herpes simplex
powder
abelmosk
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100675657A
Other languages
Chinese (zh)
Other versions
CN103202943B (en
Inventor
余金标
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310067565.7A priority Critical patent/CN103202943B/en
Publication of CN103202943A publication Critical patent/CN103202943A/en
Application granted granted Critical
Publication of CN103202943B publication Critical patent/CN103202943B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a powder for treating herpes simplex by using abelmosk. The powder comprises the following raw materials by weight : 28-32 parts of abelmosk, 13-17 parts of indigo naturalis, 8-12 parts of ginseng, 8-12 parts of Cortex Phellodendri, 2-6 parts of loofah vine, 6-10 parts of gotu kola, 2-6 parts of herba lycopi, 3-7 parts of purslane, 2-6 parts of pangolin, 3-7 parts of gallnut, 1-5 parts of sophora flower, 18-22 parts of cortex dictamni, 8-12 parts of smoked plum, 45-55 parts of calcined gypsum and 8-12 parts of Anemarrhena. The formula provided by the invention employs characteristics of abelmosk and combines some traditional Chinese medicines with effects of astringing dampness, promoting granulation, restraining sores, stopping bleeding, clearing heat and detoxifying, can achieve purposes of rapid itching relief and pain relief, and has good curative effect and short course of treatment for the treatment of herpes simplex.

Description

A kind of powder that utilizes the Okra in treatment herpes simplex
Technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of powder that utilizes the Okra in treatment herpes simplex.
Background technology:
Herpes simplex (Herpes Simplex) is a kind of by the viral dermatosis due to the herpes simplex virus.The traditional Chinese medical science is called herpes simplex.At present, the Chinese medicine and western medicine curative effect that is used for the treatment of herpes simplex is not obvious, and the course for the treatment of is long.
Summary of the invention:
The object of the invention is exactly in order to remedy the defective of prior art, a kind of powder that utilizes the Okra in treatment herpes simplex to be provided, its treatment herpes simplex short treating period, good effect.
The present invention is achieved by the following technical solutions:
A kind of powder that utilizes the Okra in treatment herpes simplex is characterized in that: the weight proportion of its each raw material components is: Radix seu folium abelmoschi moschati 28-32, Indigo Naturalis 13-17, Radix Ginseng 8-12, Cortex Phellodendri 8-12, Ramulus Luffae 2-6, Gotu Kola 6-10, Herba Lycopi 2-6, Herba Portulacae 3-7, Squama Manis 2-6, Galla Chinensis 3-7, Flos Sophorae 1-5, Cortex Dictamni 18-22, Fructus Mume 8-12, Gypsum Fibrosum Preparatum 45-55, Rhizoma Anemarrhenae 8-12.
A kind of powder that utilizes the Okra in treatment herpes simplex is characterized in that: the weight proportion of its each raw material components is: Radix seu folium abelmoschi moschati 30, Indigo Naturalis 15, Radix Ginseng 10, Cortex Phellodendri 10, Ramulus Luffae 4, Gotu Kola 8, Herba Lycopi 4, Herba Portulacae 5, Squama Manis 4, Galla Chinensis 5, Flos Sophorae 3, Cortex Dictamni 20, Fructus Mume 10, Gypsum Fibrosum Preparatum 50, the Rhizoma Anemarrhenae 10.
Radix seu folium abelmoschi moschati, [meridian distribution of property and flavor] is little sweet, cold.[function cures mainly] clearing away heat-damp and promoting diuresis, the evacuation of pus of drawing out pus by applying a plaster to the affected part.
Advantage of the present invention is:
The present invention's prescription utilizes the performance of Radix seu folium abelmoschi moschati and cooperates some removing dampnesss, and granulation promoting is held back skin ulcer, hemostasis, and the Chinese medicine of heat-clearing and toxic substances removing can reach antipruritic, aim of alleviating pain fast, for the good effect for the treatment of herpes simplex, short treating period.
The specific embodiment:
A kind of powder that utilizes the Okra in treatment herpes simplex, the weight of its each raw material components (g) is: Radix seu folium abelmoschi moschati 30, Indigo Naturalis 15, Radix Ginseng 10, Cortex Phellodendri 10, Ramulus Luffae 4, Gotu Kola 8, Herba Lycopi 4, Herba Portulacae 5, Squama Manis 4, Galla Chinensis 5, Flos Sophorae 3, Cortex Dictamni 20, Fructus Mume 10, Gypsum Fibrosum Preparatum 50, the Rhizoma Anemarrhenae 10.
Above-mentioned raw material of Chinese medicine is dried, be ground into thin medicated powder, cross 120 mesh sieves, it is standby to bottle, powder agent medicine.The using method of medicated powder of the present invention is: dip in the direct external application of medicated powder in the affected part with absorbent liquor ball, every day 3-4 time, each consumption is decided on the wound surface size.Cure about a general week.
The present invention has better curative effect for proof, and it is as follows to enumerate model case:
1, Wang, man, 15 years old.Forehead is from the beginning of several pieces intensive pimples, and ulceration on the secondth is itched and bitterly also deposited, and burning sensation is arranged, one week of the course of disease.Clean back external application Chinese medicine of the present invention, sepage reduces after 2 days, and the alleviation of pain of itching is light, begins incrustation after 5 days, and all backs crust comes off successively, wound healing, and the pain of itching disappears.
2, Zhao, man, 23 years old.The skin ulcer of 2 centimetres of sizes of chin meeting diameter has yellow transudate, with pruritus, pain, and the course of disease 6 days.Clean back external application Chinese medicine of the present invention, sepage alleviates after 3 days, and the 5th begins incrustation, and the pain of itching obviously alleviates, and crust comes off successively after seven days, and new skin bears.
3, money, man, 28 years old.Excessive skin ulcer in blocks is invaded in the lower jaw part meeting, and pruritus has burning sensation, oozes out yellow liquid, the course of disease 8 days.Clean back external application Chinese medicine of the present invention, three times on the one, crust comes off successively after seven days, the epidermis newborn skin that takes on a red color, and pruritus disappears.

Claims (2)

1. powder that utilizes the Okra in treatment herpes simplex, it is characterized in that: the weight proportion of its each raw material components is: Radix seu folium abelmoschi moschati 28-32, Indigo Naturalis 13-17, Radix Ginseng 8-12, Cortex Phellodendri 8-12, Ramulus Luffae 2-6, Gotu Kola 6-10, Herba Lycopi 2-6, Herba Portulacae 3-7, Squama Manis 2-6, Galla Chinensis 3-7, Flos Sophorae 1-5, Cortex Dictamni 18-22, Fructus Mume 8-12, Gypsum Fibrosum Preparatum 45-55, Rhizoma Anemarrhenae 8-12.
2. a kind of powder that utilizes the Okra in treatment herpes simplex according to claim 1, it is characterized in that: the weight proportion of its each raw material components is: Radix seu folium abelmoschi moschati 30, Indigo Naturalis 15, Radix Ginseng 10, Cortex Phellodendri 10, Ramulus Luffae 4, Gotu Kola 8, Herba Lycopi 4, Herba Portulacae 5, Squama Manis 4, Galla Chinensis 5, Flos Sophorae 3, Cortex Dictamni 20, Fructus Mume 10, Gypsum Fibrosum Preparatum 50, the Rhizoma Anemarrhenae 10.
CN201310067565.7A 2013-03-04 2013-03-04 Powder for treating herpes simplex by using abelmosk Expired - Fee Related CN103202943B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310067565.7A CN103202943B (en) 2013-03-04 2013-03-04 Powder for treating herpes simplex by using abelmosk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310067565.7A CN103202943B (en) 2013-03-04 2013-03-04 Powder for treating herpes simplex by using abelmosk

Publications (2)

Publication Number Publication Date
CN103202943A true CN103202943A (en) 2013-07-17
CN103202943B CN103202943B (en) 2014-07-02

Family

ID=48750497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310067565.7A Expired - Fee Related CN103202943B (en) 2013-03-04 2013-03-04 Powder for treating herpes simplex by using abelmosk

Country Status (1)

Country Link
CN (1) CN103202943B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110725A (en) * 2012-12-11 2013-05-22 余金标 Medicine for treating herpes simplex
CN104096128A (en) * 2014-07-02 2014-10-15 魏本雪 Traditional Chinese medical powder for treating pompholyx
CN105168777A (en) * 2015-09-18 2015-12-23 韦俊民 Traditional Chinese medicine for treating herpes simplex

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038853A (en) * 2009-10-20 2011-05-04 焦趁英 Externally applied plaster for treating herpes zoster

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038853A (en) * 2009-10-20 2011-05-04 焦趁英 Externally applied plaster for treating herpes zoster

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
无: "《湿疹及皮炎》", 《中国医学文摘-皮肤科学》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110725A (en) * 2012-12-11 2013-05-22 余金标 Medicine for treating herpes simplex
CN103110725B (en) * 2012-12-11 2014-07-02 余金标 Medicine for treating herpes simplex
CN104096128A (en) * 2014-07-02 2014-10-15 魏本雪 Traditional Chinese medical powder for treating pompholyx
CN105168777A (en) * 2015-09-18 2015-12-23 韦俊民 Traditional Chinese medicine for treating herpes simplex

Also Published As

Publication number Publication date
CN103202943B (en) 2014-07-02

Similar Documents

Publication Publication Date Title
CN101385822B (en) Medicine for mainly treating crural ulcer and preparation method thereof
CN103356792A (en) Chinese medicine composition for treating chronic rhinitis
CN103202943B (en) Powder for treating herpes simplex by using abelmosk
CN103432374A (en) Medicine for treating pneumonia of pig
CN103638504A (en) Traditional Chinese medicine granule for treating infantile common cold and preparation method thereof
CN104027557A (en) Traditional Chinese medicine composition for treating folliculitis
CN103566214A (en) Musk blood-invigorating and pain-relieving paste
CN102743602A (en) Medicine prepared from Chinese herbal medicines and used for treating rhinitis and nasosinusitis
CN102302622A (en) Traditional Chinese medicine used for treating radiodermatitis
CN104984148A (en) Traditional Chinese medicine composite for wound care in clinical application
CN103110725B (en) Medicine for treating herpes simplex
CN105616662A (en) Traditional Chinese medicine composition for treating solar dermatitis
CN104491825A (en) Traditional Chinese medicine ointment for treating canker sores
CN103316155B (en) Traditional Chinese medicinal composition for treating constipation and preparation method thereof
CN103638106A (en) Skin whitening and antiallergic traditional Chinese medicine composition
CN103599506A (en) Traditional Chinese medicine for treating urticaria
CN105497422A (en) Externally-applied traditional Chinese medicine for treating infantile eczema
CN104623278A (en) External traditional Chinese medicine for treating heat toxin type acne
CN105521326A (en) Traditional Chinese medicine for treating hebra prurigo
CN105233162A (en) Traditional Chinese medicine composition for treating chronic cholecystitis, and preparation method and pharmaceuticals thereof
CN105031180A (en) Traditional Chinese medicine preparation for treating fever and preparation method thereof
CN105497350A (en) Traditional Chinese medicine for treating pseudopelade
CN103989953A (en) Traditional Chinese medicinal composition for treating infantile paralysis
CN104587241A (en) Traditional Chinese medicine composition for treating acute tracheitis
CN104056143A (en) Traditional Chinese medicine composition for treating scabies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140702

Termination date: 20150304

EXPY Termination of patent right or utility model